Mei C, Xu G, Zheng C, Xie Y, Li M, Shao Y, Yao R, Tao S, Jiang W, Guo J, Zheng Z, Wang W, Zhou X, Ma L, Ye L, Luo Y, Yang C, Yu W, Xie W, Jin J, Tong H. Recombinant human erythropoietin plus all-<i>trans</i&gt; retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial. Haematologica 2026;111(2):646-655; https://doi.org/10.3324/haematol.2024.287055.